Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Jul;74(1):25–38. doi: 10.1172/JCI111409

A ganglioside antigen on the rat pancreatic B cell surface identified by monoclonal antibody R2D6.

R Alejandro, F L Shienvold, S A Hajek, M Pierce, R Paul, D H Mintz
PMCID: PMC425181  PMID: 6376545

Abstract

In an attempt to identify B cell specific antigens, we have generated a mouse monoclonal antibody, R2D6, which is directed against plasma membranes of rat pancreatic B cells but against no other pancreatic cells. R2D6 crossreacted with mouse and guinea pig B cells, but not with human or dog. The B cell specificity of R2D6 was utilized in fluorescence-activated cell sorting to prepare highly enriched separate populations of viable pancreatic islet B cells and A cells. R2D6 also recognized adrenal chromaffin cells, secretory cells in the anterior pituitary, and the myenteric plexus of the gastrointestinal tract. Trypsin, chymotrypsin, papain, ficin, and pronase had no effect on R2D6-binding to dissociated rat islet cells. However, neuraminidase treatment of intact cells reduced R2D6-binding by 75%. The antigen recognized by R2D6, Ag(R2D6), could be quantitatively extracted from rat islets by dichloromethane/methanol (2:1) and, after drying, was soluble in methanol alone as well as in phosphate-buffered saline. When the dichloromethane/methanol extract (DME) was bound to polyvinylchloride microtiter plates, antigenic activity was retained and remained insensitive to pronase. In this solvent-extracted form, antigenic activity was totally destroyed by neuraminidase. Therefore, sialic acid is either an integral part of, or is related sterically to the binding site (epitope) for R2D6. In high performance thin-layer chromatographs of the DME, developed in 60:40:9 chloroform/methanol/2.5 N ammonia, Ag(R2D6) migrated with a relative mobility (Rf) of 0.54 +/- 0.07 (n = 3), which was a position nearly coincident with the purified brain ganglioside, GD1a. The antigen bound to DEAE-Sephacel, was not inactivated by mild treatment with base (which hydrolyzes phospholipids) and eluted in ganglioside fractions upon C18 Sep-Pak and upon silicic acid chromatography. Hence, the solubility characteristics, enzyme sensitivities, and behavior of Ag(R2D6) in four chromatography systems are consistent with its identification as a ganglioside.

Full text

PDF
25

Images in this article

30Image
on p.30
30Image
on p.30
31Image
on p.31
31Image
on p.31
32Image
on p.32
32Image
on p.32
32Image
on p.32
32Image
on p.32
34Image
on p.34
34Image
on p.34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alejandro R., Shienvold F. L., Hajek S. V., Ryan U., Miller J., Mintz D. H. Immunocytochemical localization of HLA-DR in human islets of Langerhans. Diabetes. 1982 Aug;31 (Suppl 4):17–22. doi: 10.2337/diab.31.4.s17. [DOI] [PubMed] [Google Scholar]
  2. Baekkeskov S., Nielsen J. H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982 Jul 8;298(5870):167–169. doi: 10.1038/298167a0. [DOI] [PubMed] [Google Scholar]
  3. Coller H. A., Coller B. S. Statistical analysis of repetitive subcloning by the limiting dilution technique with a view toward ensuring hybridoma monoclonality. Hybridoma. 1983;2(1):91–96. doi: 10.1089/hyb.1983.2.91. [DOI] [PubMed] [Google Scholar]
  4. Crump M. A., Scearce R., Dobersen M., Kortz W., Eisenbarth G. S. Production and characterization of a cytotoxic monoclonal antibody reacting with rat islet cells. J Clin Invest. 1982 Sep;70(3):659–666. doi: 10.1172/JCI110660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dobersen M. J., Scharff J. E. Preferential lysis of pancreatic B-cells by islet cell surface antibodies. Diabetes. 1982 May;31(5 Pt 1):459–462. doi: 10.2337/diab.31.5.459. [DOI] [PubMed] [Google Scholar]
  6. Eisenbarth G. S., Haynes B. F., Schroer J. A., Fauci A. S. Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J Immunol. 1980 Mar;124(3):1237–1244. [PubMed] [Google Scholar]
  7. Eisenbarth G. S., Shimizu K., Bowring M. A., Wells S. Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. Proc Natl Acad Sci U S A. 1982 Aug;79(16):5066–5070. doi: 10.1073/pnas.79.16.5066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eisenbarth G. S., Walsh F. S., Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4913–4917. doi: 10.1073/pnas.76.10.4913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erickson P. F., Minier L. N., Lasher R. S. Quantitative electrophoretic transfer of polypeptides from SDS polyacrylamide gels to nitrocellulose sheets: a method for their re-use in immunoautoradiographic detection of antigens. J Immunol Methods. 1982 Jun 11;51(2):241–249. doi: 10.1016/0022-1759(82)90263-0. [DOI] [PubMed] [Google Scholar]
  10. Fishman P. H. Role of membrane gangliosides in the binding and action of bacterial toxins. J Membr Biol. 1982;69(2):85–97. doi: 10.1007/BF01872268. [DOI] [PubMed] [Google Scholar]
  11. Fletcher D. J., Grogan W. M., Barras E., Weir G. C. Hormone release by islet B cell-enriched and A and D cell-enriched populations prepared by flow cytometry. Endocrinology. 1983 Nov;113(5):1791–1798. doi: 10.1210/endo-113-5-1791. [DOI] [PubMed] [Google Scholar]
  12. Galfrè G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3–46. doi: 10.1016/0076-6879(81)73054-4. [DOI] [PubMed] [Google Scholar]
  13. Haspel M. V., Onodera T., Prabhakar B. S., Horita M., Suzuki H., Notkins A. L. Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science. 1983 Apr 15;220(4594):304–306. doi: 10.1126/science.6301002. [DOI] [PubMed] [Google Scholar]
  14. Haspel M. V., Onodera T., Prabhakar B. S., McClintock P. R., Essani K., Ray U. R., Yagihashi S., Notkins A. L. Multiple organ-reactive monoclonal autoantibodies. Nature. 1983 Jul 7;304(5921):73–76. doi: 10.1038/304073a0. [DOI] [PubMed] [Google Scholar]
  15. Haynes B. F., Shimizu K., Eisenbarth G. S. Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5. J Clin Invest. 1983 Jan;71(1):9–14. doi: 10.1172/JCI110755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hubbard A. L., Cohn Z. A. Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells. J Cell Biol. 1975 Feb;64(2):438–460. doi: 10.1083/jcb.64.2.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hughes E. N., August J. T. Characterization of plasma membrane proteins identified by monoclonal antibodies. J Biol Chem. 1981 Jan 25;256(2):664–671. [PubMed] [Google Scholar]
  18. Häyry P., Tötterman T. H., Ranki A. Lack of subclass selection during density purification of human lymphocytes. Clin Exp Immunol. 1977 May;28(2):341–346. [PMC free article] [PubMed] [Google Scholar]
  19. Irvine W. J. Autoimmunity in endocrine disease. Recent Prog Horm Res. 1980;36:509–556. doi: 10.1016/b978-0-12-571136-4.50020-6. [DOI] [PubMed] [Google Scholar]
  20. Kanatsuna T., Baekkeskov S., Lernmark A., Ludvigsson J. Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes. 1983 Jun;32(6):520–524. doi: 10.2337/diab.32.6.520. [DOI] [PubMed] [Google Scholar]
  21. Lacy P. E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967 Jan;16(1):35–39. doi: 10.2337/diab.16.1.35. [DOI] [PubMed] [Google Scholar]
  22. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  23. Lernmark A., Hägglöf B., Freedman Z., Irvine J., Ludvigsson J., Holmgren G. A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia. 1981 Apr;20(4):471–474. doi: 10.1007/BF00253410. [DOI] [PubMed] [Google Scholar]
  24. Magnani J. L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem. 1982 Dec 10;257(23):14365–14369. [PubMed] [Google Scholar]
  25. Meda P., Hooghe-Peters E. L., Orci L. Monolayer cultures of adult pancreatic islet cells on osmotically disrupted fibroblasts. Diabetes. 1980 Jun;29(6):497–500. doi: 10.2337/diab.29.6.497. [DOI] [PubMed] [Google Scholar]
  26. Mirakian R., Cudworth A. G., Bottazzo G. F., Richardson C. A., Doniach D. Autoimmunity to anterior pituitary cells and the pathogenesis of insulin-dependent diabetes mellitus. Lancet. 1982 Apr 3;1(8275):755–759. doi: 10.1016/s0140-6736(82)91809-8. [DOI] [PubMed] [Google Scholar]
  27. Nielsen D. A., Lernmark A., Berelowitz M., Bloom G. D., Steiner D. F. Sorting of pancreatic islet cell subpopulations by light scattering using a fluorescence-activated cell sorter. Diabetes. 1982 Apr;31(4 Pt 1):299–306. doi: 10.2337/diab.31.4.299. [DOI] [PubMed] [Google Scholar]
  28. Pipeleers D. G., Pipeleers-Marichal M. A. A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia. 1981 Jun;20(6):654–663. doi: 10.1007/BF00257436. [DOI] [PubMed] [Google Scholar]
  29. Pujol-Borrell R., Khoury E. L., Bottazzo G. F. Islet cell surface antibodies in type 1 (insulin-dependent) diabetes mellitus: use of human fetal pancreas cultures as substrate. Diabetologia. 1982 Feb;22(2):89–95. doi: 10.1007/BF00254835. [DOI] [PubMed] [Google Scholar]
  30. Rabinovitch A., Russell T., Shienvold F., Noel J., Files N., Patel Y., Ingram M. Preparation of rat islet B-cell-enriched fractions by light-scatter flow cytometry. Diabetes. 1982 Nov;31(11):939–943. doi: 10.2337/diacare.31.11.939. [DOI] [PubMed] [Google Scholar]
  31. Satoh J., Prabhakar B. S., Haspel M. V., Ginsberg-Fellner F., Notkins A. L. Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med. 1983 Jul 28;309(4):217–220. doi: 10.1056/NEJM198307283090405. [DOI] [PubMed] [Google Scholar]
  32. Shulman M., Wilde C. D., Köhler G. A better cell line for making hybridomas secreting specific antibodies. Nature. 1978 Nov 16;276(5685):269–270. doi: 10.1038/276269a0. [DOI] [PubMed] [Google Scholar]
  33. Van De Winkel M., Smets G., Gepts W., Pipeleers D. Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells. J Clin Invest. 1982 Jul;70(1):41–49. doi: 10.1172/JCI110601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Van de Winkle M., Maes E., Pipeleers D. Islet cell analysis and purification by light scatter and autofluorescence. Biochem Biophys Res Commun. 1982 Jul 30;107(2):525–532. doi: 10.1016/0006-291x(82)91523-6. [DOI] [PubMed] [Google Scholar]
  35. Wollheim C. B., Blondel B., Sharp G. W. Effect of cholera toxin on insulin release in monolayer cultures of the endocrine pancreas. Diabetologia. 1974 Dec;10(6):783–787. doi: 10.1007/BF01219541. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES